You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 13, 2025

Details for Patent: 3,655,663


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,655,663
Title:4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
Abstract:4-(3-(SUBSTITUTED AMINO)-2-HYDROXUPROPOXY)-1,2,5-THIADIAZOLE COMPOUNDS, OPTIONALLY SUBSTITUTED IN THE 3-POSITION OF THE THIADIAZOLE NUCLEUS WHICH EXHIBITS B-ADRENERGIC BLOCKING PROPERTIES AND THUS ARE USEFUL IN THE MANAGEMENT OF ANGINA PECTORIS ARE DESCRIBED. THE PRODUCTS ARE PREPARED BY ONE OF FOUR PRINCIPAL METHODS (1) REACTION OF A 4-HYDROXY-1,2,5-THIADIAZOLE WITH EPIHALOYDRINE TO PROVIDE 4-(3 HALO-2-HYDROXYPROPOXY)-1,2,5-THIADIAZOLE WHICH UPON TREATMENT WIHT ALKALI, FORMS THE EPOXIDE WHICH IS THEN REACTED WITH AN AMINE TO PROVIDE THE DESIRED PRODUCT; (2) REACTION OF A 3-CHLORO(OR BROMO)-4-(3-SUBSTITUTED AMINO-2-HYDROXYPROPOXY)-1,2,5-THIADIAZOLE WITH AN AMINE OR AN N-CONTAINING HETEROCYCLE THAT REPLACES THE 3-CHLOROGROUP; (3) REACTION OF 3-CARBOXY-4-ALLYLOXY-1,2,5-THIADIAZOLE WITH N-BROMOSUCCINIMIDE FOLLOWED BY ESTERIFICATION TO GIVE THE ALKYL ESTER OF 3-CARBOXY-4(3-BROMO-2-HYDROXYPROPOXYL)-1,2,5-THIADIAZOLE WHICH UPON TREATMENT WITH AN AMINE FORMS A 3-CARBONOYL-4-(3SUBSTITUTED AMINO-2-HYDROXYPROPOXY)-1,2,5-THIADIAZOLE AND (4) REDUCTIVE ALKYLATION OF AN R-O-CH2-CO-CH-N2, R-O-CH2-CO-CN3, R-O-CH2-CO-CH=N-OH, R-O-CH2-CO-CH2-NO2, R-O-CH2-CH(-OH)-CH2-NO2, R-O-CH2-CH(-OH)-CN, OR R-O-CH2-CO-CN WHEREIN R IS THE 1,2,5-THIADIAZOLE-4-YL GROUP.
Inventor(s):Burton K Wasson
Assignee:CHARLES & FROSST & Co A CORP OF PROVINCE OF QUEBEC CANADA, BURTON K WASSON
Application Number:US818090A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

United States Patent 3,655,663: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 3,655,663 is a significant patent that has been the focus of various analyses, particularly in the pharmaceutical industry. This patent, like many others, involves a complex interplay of claims, scope, and its position within the broader patent landscape. Here, we will delve into the details of this patent, exploring its claims, scope, and the broader implications within the patent ecosystem.

Background of the Patent

Patent 3,655,663 was issued for a specific pharmaceutical compound, which is often the subject of detailed analysis in terms of its chemical composition, therapeutic uses, and patent protection. To understand this patent, it is crucial to look at the context in which it was granted and the current status of its protection.

Claims of the Patent

The claims of a patent are the most critical part as they define the scope of the invention and what is protected under the patent. For Patent 3,655,663, the claims would typically include:

  • Independent Claims: These are the broadest claims that define the invention. They are crucial because they set the boundaries of what is considered novel and non-obvious[3].
  • Dependent Claims: These claims are narrower and build upon the independent claims, often adding specific details or limitations to the invention.
  • Claim Language: The language used in the claims is vital. Metrics such as independent claim length and independent claim count can provide insights into the patent's scope and quality[3].

Scope of the Patent

The scope of a patent is determined by its claims and is a key factor in patent quality debates. Here are some aspects to consider:

  • Patent Scope Metrics: Research has shown that metrics like independent claim length and count can be used to measure patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].
  • Examination Process: The patent examination process often narrows the scope of patent claims. This is evident from studies that show significant changes in claim length and count during the examination period[3].

Patent Landscape

Understanding the patent landscape involves looking at how this patent fits into the broader ecosystem of related patents and intellectual property.

Global Dossier and International Patent Offices

To assess the global impact of Patent 3,655,663, one must consider its presence in international patent databases. Tools like the Global Dossier and databases from the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) provide insights into related applications and citations across different jurisdictions[1].

Related Patents and Citations

The Common Citation Document (CCD) application is useful here, as it consolidates citation data from multiple offices, allowing for a comprehensive view of prior art and related inventions[1].

Patent Family and Dossier

The patent family for 3,655,663, including all related applications filed at participating IP Offices, can be accessed through the Global Dossier. This provides classification, citation data, and office action indicators, which are essential for understanding the patent's global reach and any challenges it may have faced[1].

Expiration and Generic Entry

Patents have a limited lifespan, and understanding when a patent expires is crucial for generic entry into the market.

  • Patent Expiration: Patent 3,655,663 would have expired after the standard 20-year term from its filing date, unless it was extended or had other special considerations.
  • Generic Entry: Once a patent expires, generic versions of the pharmaceutical compound can enter the market. This is a significant event in the pharmaceutical industry as it can lead to increased competition and reduced prices[2].

Search and Analysis Tools

Several tools are available for searching and analyzing patents, which can provide deeper insights into Patent 3,655,663:

  • Patent Public Search: This tool offers enhanced access to prior art and is a powerful resource for searching U.S. patents[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques, which can be invaluable for detailed analysis[1].

Conclusion

Patent 3,655,663 is a complex entity within the broader patent landscape. Understanding its claims, scope, and position within this landscape is essential for both legal and business strategies. By using various search and analysis tools, one can gain a comprehensive view of the patent's significance and its impact on the pharmaceutical industry.

Key Takeaways

  • Claims Define Scope: The claims of a patent are crucial in defining its scope and what is protected.
  • Patent Scope Metrics: Metrics like independent claim length and count can measure patent scope and quality.
  • Global Impact: Tools like the Global Dossier and international patent databases help in understanding the global reach of a patent.
  • Expiration and Generic Entry: Understanding patent expiration dates is critical for anticipating generic entry into the market.
  • Search and Analysis Tools: Various tools are available for detailed patent searches and analyses.

FAQs

What is the significance of independent claims in a patent?

Independent claims are the broadest claims that define the invention and set the boundaries of what is considered novel and non-obvious.

How can the scope of a patent be measured?

The scope of a patent can be measured using metrics such as independent claim length and independent claim count.

What is the Global Dossier, and how does it help in patent searches?

The Global Dossier is a service that provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family, classification, and citation data for these applications.

When does a patent typically expire?

A patent typically expires after a 20-year term from its filing date, unless it is extended or has other special considerations.

What happens when a pharmaceutical patent expires?

When a pharmaceutical patent expires, generic versions of the compound can enter the market, leading to increased competition and reduced prices.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. DrugPatentWatch - Patent 3,655,663: https://www.drugpatentwatch.com/p/patent/3655663
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. NCSES - Invention, Knowledge Transfer, and Innovation: https://ncses.nsf.gov/pubs/nsb20241/technical-appendix
  5. PubChem - N-alkyl-n-(alkylated-benzyl)dihaloacetamides: https://pubchem.ncbi.nlm.nih.gov/patent/US-2862967-A

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 3,655,663

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 3,655,663

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Austria 288378 ⤷  Try for Free
Austria 289788 ⤷  Try for Free
Austria 289789 ⤷  Try for Free
Austria 294830 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.